
ALT Marking its 10th anniversary, the Wadhwani Research Centre for Bioengineering (WRCB), IIT Bombay, looks back on a decade of advancing India’s bioengineering ecosystem — through translational research, start-up incubation, and partnerships that bridge academia, industry, and society. In our October edition of Bio-Ignite, we highlight how WRCB continues to strengthen the innovation-to-impact pipeline — with inspiring updates from WRCB-supported start-ups that recently received commercialization grants backed by the Wadhwani Foundation — Algorithmic Biologics, AmyScan Healthcare, UrjanovaC, and Clarity BioSystems. This issue also features insights from Prof. Debabrata Maiti’s PRISM Talk and a research spotlight on microfluidic innovations by Prof. Debjani Paul’s group. We also celebrate our student entrepreneur, Dr. Preethi Arul Murugan, on receiving the DST INSPIRE Faculty Fellowship at IISc Bengaluru. Also stay tuned for updates on our upcoming Roundtable on Antimicrobial Resistance!

ALT At WRCB, our mission is to enable translational research that leads to affordable healthcare solutions — and moments like these remind us why we do what we do. The startup Akstherzen Pvt. Ltd., has emerged from their WRCB-supported project “Development of latex-based iodinated beads (iBeads) for the treatment of Surgical Infections” (supported in 2023). Hariharan shared, “I am deeply obliged to WRCB for their generous support and mentorship, which have been instrumental in shaping my entrepreneurial and translational research journey. What began as a scientific quest has evolved into a promising initiative focused on developing antibacterial beads for the treatment of surgical site and bone infections — aimed at addressing unmet clinical needs through innovation." 👏 Thank you, Hariharan, for your inspiring words! We are proud to have been part of your journey and even more excited to see young entrepreneurs like you transforming research into impact.

ALT Wadhwani Research Centre for Bioengineering (WRCB) IIT Bombay had the privilege of supporting Dr. Mansi Upadhyay and Prof. Ashutosh Kumar in their project titled: “Chewable Nanoformulation for the Management of Type 2 Diabetes.” This innovative project aims to develop a painless, oral, chewable nanoformulation that co-delivers two drugs — Liraglutide (a peptide-based glucose-lowering drug) and Myricetin (a natural flavonoid with anti-amyloid and anti-diabetic properties). The formulation is designed to make diabetes treatment needle-free, patient-friendly, and synergistically effective in addressing the root causes of Type 2 Diabetes Mellitus (T2DM). The project represents an important step toward accessible and compliant diabetes care, especially for patients struggling with injection-based therapies. Dr. Mansi’s journey — from her research at IIT Bombay, publication and patent milestones, to now guiding young minds at MAHE — exemplifies how WRCB-supported translational research can

ALT As Wadhwani Research Centre for Bioengineering (WRCB) IIT Bombay marks its 10-year journey, we reflect on a decade of driving translational research—nurturing start-ups, enabling breakthrough technologies, and forging impactful partnerships with industry and donors. In this edition, we bring you the highlights of our milestone initiatives — the launch of the WRCB-Bioinnovation Laboratory (supported by HiMedia Laboratories Pvt. Ltd.), exciting new partnerships, and other key events including our flagship Paid Internship Program, the PRISM Colloquium, the 13th Call for Proposals, and more! We invite you to explore these updates and join us in celebrating the collective progress of our vibrant ecosystem. To learn more about WRCB’s research and activities, DM us in LinkedIn or write to us at [email protected].



















